The FDAs job is to ensure that drugs, supplements, and medical treatments are both safe and effective before they reach the public
2,3 REDEFINE 1 was a 68-week, double-blind, randomized, placebo- and active-controlled phase 3 trial that evaluated the efficacy and safety of once-weekly CagriSema versus cagrilintide 2.4 mg monotherapy, semaglutide 2.4 mg monotherapy, and placebo, all in combination with lifestyle intervention in 3,417 adults with obesity or overweight with one or more obesity-related complications and without type 2 diabetes
How to test and monitor BDNF levels Measuring BDNF is possible, practical, and increasingly accessible
Compounding legally prohibited in the US (FDA Category 2 from 2023 to April 2026
Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metabolism.
Functional Divergence between Histone Deacetylases in Fission Yeast by Distinct Cellular Localization and In Vivo Specificity